Anaesthesia and right ventricular failure

Anaesthesia and Intensive Care

Volumn 37, Issue 3, 2009, Pages 370-385

  Forrest, P ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Anaesthesia; Perioperative; Pulmonary hypertension; Right heart failure; Right ventricular failure

Indexed keywords

ADRENALIN; DESFLURANE; DOBUTAMINE; ENFLURANE; ETOMIDATE; FENTANYL; HALOTHANE; ILOPROST; ISOFLURANE; KETAMINE; LEVOSIMENDAN; MILRINONE; NORADRENALIN; PROPOFOL; REMIFENTANIL; SILDENAFIL; SUFENTANIL; THIOPENTAL; VASOPRESSIN;

ANESTHESIA; ARTICLE; BLOOD PRESSURE MONITORING; CENTRAL VENOUS PRESSURE; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEART VENTRICLE CONTRACTION; HEART VENTRICLE PRESSURE; HEART VENTRICLE VOLUME; HUMAN; LUNG VASCULAR RESISTANCE;

EID: 66449134538     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0903700314     Document Type: Article

References (162)

1. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112:154-235.
2. The international primary pulmonary hypertension study (IPPHS). Chest 1994; 105:37S-41S.
3. Budev MM, Arroliga AC, Jennings CA. Diagnosis and evaluation of pulmonary hypertension. Cleve Clin J Med 2003; 70 (Suppl 1):S9-17.
4. Reich D, Bodian C, Krol M, Kuroda M, Osinski T, Thys D. Intraoperative hemodynamic predictors of mortality, stroke and myocardial infarction after coronary artery bypass surgery. Anesth Analg 1999; 89:814-882. (Pubitemid 29458450)
5. Ramakrishna G, Sprung J, Barugar S, Chandrasekaran K, McGoon M. Impact of pulmonary hypertension on the outcomes of noncardiac surgery. J Am Coll Cardiol 2005; 45:1691-1699.
6. Lai H, Lai H, Wnag K, Lee W, Ting C, Liu T. Severe pulmonary hypertension complicates outcome of non-cardiac surgery. BJA 2007; 99:184-190. (Pubitemid 47249389)
7. Zapol W, Snider M. Pulmonary hypertension in severe acute respiratory failure. N Engl J Med 1977; 296:476-480. (Pubitemid 8038309)
8. Fischer L, Van Aken H, Burkle H. Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesth Analg 2003; 96:1603-1616. (Pubitemid 36623112)
9. Lowenstein E, Johnston WE, Lappas DG, D'Ambra MN, Schneider RC, Daggett WM et al. Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin. Anesthesiology 1983; 59:470-473. (Pubitemid 14227526)
10. Irita K, Kawashima T, Iwao Y, Seo N, Tsuzaki K, Morita K et al. Annual mortality and morbidity in operating rooms during 2002 and summary of morbidity and mortality between 1999 and 2002 in Japan: a brief review. Masui 2004; 53:320-335.
11. Ramzan Z, Al-Dehneh A, Maher J. Right ventricular failure in patients with preserved ejection fraction and diastolic dysfunction: an underrecognized clinical entity. Congest Heart Fail 2007; 13:164-169.
12. Pegg T, Selvanayagam J, Karamitsos T, Arnold R, Francis J, Neubauer S et al. Effects of on-pump versus off-pump coronary artery bypass grafting on early and late right ventricular function. Circulation 2008; 117:2202-2210.
13. Vlahakes G. Right ventricular failure following cardiac surgery. Coron Artery Dis 2005; 16:27-30. (Pubitemid 40279594)
14. Kinch JW, Ryan TJ. Right ventricular infarction. N Engl J Med 1994; 330:1211-1217. (Pubitemid 24984693)
15. Santamore W, Gray L. Left ventricular contributions to right ventricular performance during LVAD support. Ann Thorac Surg 1996; 61:350-356. (Pubitemid 26053537)
16. Kaul T, Fields B. Postoperative acute refractory right ventricular failure: incidence, pathogenesis, management and prognosis. Cardiovasc Surg 2000; 8:1-9.
17. Russell I, Rouine-Rapp K, Stratmann G, Miller-Hance W. Congenital heart disease in the adult: a review with internet-accessible transoesophageal echocardiographic images. Anesth Analg 2006; 102:694-723. (Pubitemid 43308319)
18. Greyson Clifford R. Pathophysiology of right ventricular failure. Crit Care Med 2007; 36:S57-65.
19. Warrell D, Evans J, Clark R, Kingaby G, West J. Pattern of filling on the pulmonary capillary bed. J Appl Physiol 1972; 32:346-356.
20. Lowensohn HS, Khouri EM, Gregg DE, Pyle RL, Patterson RE. Phasic right coronary artery blood flow in conscious dogs with normal and elevated right ventricular pressures. Circ Res 1976; 39:760-766. (Pubitemid 8002298)
21. Dell'Italia L. The right ventricle: anatomy, physiology and clinical importance. Curr Probl Cardiol 1991; 16:653-720.
22. Goldstein JA, Barzilai B, Rosamond TL, Eisenberg PR, Jaffe AS. Determinants of hemodynamic compromise with severe right ventricular infarction. Circulation 1990; 82:359-368. (Pubitemid 20257814)
23. Klima U, Guerrero J, Vlahakes G. Contribution of the interventricular septum to maximal right ventricular function. Eur J Cardiothorac Surg 1998; 14:250-255. (Pubitemid 28417077)
24. Szabo G, Soos P, Bahrle S. Adaptation of the right ventricle to an increased afterload in the chronically volume overloaded heart. Ann Thorac Surg 2006; 82:989-995. (Pubitemid 44246713)
25. Santamore W, Dell'Italia J. Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function. Prog Cardiovasc Dis 1998; 40:289-308. (Pubitemid 28060410)
26. Ishibashi Y, Rembert JC, Carabello BA, Nemoto S, Hamawaki M, Zile MR et al. Normal myocardial function in severe right ventricular volume overload hypertrophy. Am J Physiol Heart Circ Physiol 2001; 280:H11-16. (Pubitemid 32493078)
27. 2+-dependent heterometric and homeometric autoregulation in hypertrophied rat heart. Am J Physiol 1989; 256:H1139-1147.
28. Nootens M, Kaufmann E, Rector T. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol 1995; 26:1581-1585.
29. Guyton A, Lindsey A, Gilluly J. The limits of right ventricular compensation following acute increases in pulmonary circulatory resistance. Circ Res 1954; 2:326-333.
30. Vlahakes GJ, Turley K, Hoffman JI. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 1981; 63:87-95. (Pubitemid 11213337)
31. Gold F, Bache R. Transmural right ventricular blood flow during acute pulmonary artery hypertension in the sedated dog. Evidence for subendocardial ischemia despite residual vasodilator reserve. Circ Res 1982; 51:196-204.
32. Lualdi J, Goldhaber S. Right ventricular dysfunction after acute pulmonary embolism: Pathophysiologic factors, detection and therapeutic implications. Am Heart J 1995; 130:1276-1282.
33. Brooks H, Kirk E, Vokonas P. Performance of the right ventricle under stress: relation to right coronary flow. J Clin Invest 1971; 50:2176-2183.
34. Sreeram G, Schroeder R, Mark J. Asssessment of right ventricular function. In: Savage and Aronson Ed.Intraoperative Transesophageal Echocardiography. Philadelphia, PA: Lippincott Williams and Wilkins 2005. p.147-157.
35. Von Scheldt W, Coastare-Jaeckle A, Stempfle H. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study. J Heart Lung Transplant 2006; 25:1070-1076. (Pubitemid 44322050)
36. Fox C, Kalarickal P, Yarborough M, Jin J. Perioperative management including new pharmacological vistas for patients with pulmonary hypertension for noncardiac surgery. Curr Opin Anaesthesiol 2008; 21:467-472.
37. O'Hare R, McLoughlin C, Milligan K, McNamee D, Sidhu H. Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertension. Brit J Anaesth 1998; 81:790-792. (Pubitemid 28499946)
38. Mogollon M, Cabezon L, Hinojosa R. Combination therapy with sildenafil and bosentan reverts severe pulmonary hypertension and allows heart transplantation: a case report. Transplant Proc 2006; 38:2522-2523.
39. Nagaya N, Sasaki N, Ando M, Ogino H, Sakamaki F, Kyotani S et al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 2003; 123:338-343. (Pubitemid 36269413)
40. Borst H, Whittenberger J, Berglund E, McGregor M. Effects of unilateral hypoxia and hypercapnia on pulmonary blood flow distribution in dogs. Am J Physiol 1957; 191:446-452.
41. Barer G, Howard P, Shaw J. Stimulus-response curves for the pulmonary vascular bed to hypoxial and hypercapnia. J Physiol 1970; 211:139-155.
42. Balanos G, Talbot N, Dorrington K, Robbins P. Human pulmonary vascular response to 4h of hypercapnia and hypocapnia measured using Doppler echocardiography. J Appl Physiol 2003; 94:1543-1551. (Pubitemid 36348834)
43. Kilburn K, Asmundsson T, Britt R, Cardon R. Effects of breathing 10% carbon dioxide on the pulmonary circulation of human subjects. Circulation 1969; 39:639-653.
44. Melot C, Naeije R, Hallesmans R, Lejeune P, Mols P. Hypoxic pulmonary vasoconstriction and pulmonary gas exchange in normal man. Respir Physiol 1987; 68:11-27. (Pubitemid 17057008)
45. Bindslev L, Jolin A, Hedenstierna G, Baehrendtz S, Santesson J. Hypoxic pulmonary vasoconstriction in the human lung: effect of repeated hypoxic challenges during anesthesia. Anesthesiology 1985; 62:621-625. (Pubitemid 15099201)
46. Marshall C, Marshall B. Site and sensitivity for stimulation of hypoxic pulmonary vasoconstriction. J Appl Physiol 1983; 55:711.
47. Nagendran J, Stewart K, Hoskinson M, Archer SL. An anesthesiologist's guide to hypoxic pulmonary vasoconstriction: implications for managing single-lung anesthesia and atelectasis. Curr Opin Anaesthesiol 2006; 19:34-43. (Pubitemid 43269474)
48. Roberts D, Lepore J, Maroo A, Semigran M, Ginns L. Oxygen therapy improves cardiac index and pulmonary vascular resistance in patients with pulmonary hypertension. Chest 2001; 120:1547-1555. (Pubitemid 33078471)
49. Lumb A, ed. Nunn's Applied Respiratory Physiology, 5th ed. Butterworth-Heinemann, Woburn, MA 2000; p. 145.
50. Lumb A, ed. Nunn's Applied Respiratory Physiology, 5th ed. Butterworth-Heinemann, Woburn, MA 2000; p. 434.
51. Fischer L, Van Aken H, Burkle H. Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesth Analg 2003; 96:1603-1616. (Pubitemid 36623112)
52. Cuenco J, Tzeng G, Wittels B. Anesthetic management of the parturient with systemic lupus erythematosus, pulmonary hypertension, and pulmonary edema. Anesthesiology 1999; 91:568-570. (Pubitemid 29365045)
53. Monnery L, Nanson J, Charlton G. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Brit J Anaesth 2001; 87:295-298. (Pubitemid 32750544)
54. Duggan AB, Katz SG. Combined spinal and epidural anaesthesia for caesarean section in a parturient with severe primary pulmonary hypertension. Anaesth Intensive Care 2003; 31:565-569. (Pubitemid 37265253)
55. Sykes M. Effects of anesthetic and drugs used during anesthesia on the pulmonary circulation. In: Altura B, Halevy S, eds. Cardiovascular actions of anesthetics and drugs used in anesthesia. Basel, Switzerland: Karger 1986. p. 92-126.
56. Gregoretti S, Gelman S, Dimick A, Bradley E. Hemodynamic changes and oxygen consumption in burned patients during enflurane or isoflurane anesthesia. Anesth Analg 1989; 69:431-436. (Pubitemid 20037363)
57. Inada T, Inada T, Kawachi S. Hemodynamic comparison of sevoflurane and isoflurane anaesthesia in surgical patients. Can J Anaesth 1997; 44:140-145. (Pubitemid 27209891)
58. Pagel P, Fu J, Damask M. Desflurane and isoflurane produce similar alteration in systemic and pulmonary hemodynamics in patients undergoing one lung ventilation during thoracotomy. Anesth Analg 1998; 87:800-807.
59. Ciofolo MJ, Reiz S. Circulatory effects of volatile anesthetic agents. Minerva Anestesiol 1999; 65:232-238.
60. Tempe D, Mohan J, Cooper A. Myocardial depressant effect of nitrous oxide after valve surgery. Eur J Anaesthesiol 1994; 11:353-358. (Pubitemid 24287762)
61. Schulte-Sasse U, Hess W, Tarnow J. Pulmonary vascular responses to nitrous oxide in patients with normal and high pulmonary vascular resistance. Anesthesiology 1982; 57:9-13. (Pubitemid 12087547)
62. Chassot Pierre-Guy, Bettex Dominique A. Anesthesia and adult congenital heart disease. J Cardiothorac Vasc Anesth 2006; 20:414-437.
63. Todd MM, Drummond JC, U HS. The hemodynamic consequences of high-dose thiopental anesthesia. Anesth Analg 1985; 64:681-687.
64. Wiedemann K, Diestelhorst C. [The effect of sedation on pulmonary function]. Anaesthesist 1996; 44 (Suppl 3):S588-593.
65. Tweed W, Minuck M, Mymin D. Circulatory responses to ketamine anesthesia. Anesthesiology 1972; 37:613-619.
66. Hickey PR, Hansen DD, Cramolini GM, Vincent RN, Lang P. Pulmonary and systemic hemodynamic responses to ketamine in infants with normal and elevated pulmonary vascular resistance. Anesthesiology 1985; 62:287-293. (Pubitemid 15101878)
67. Williams GD, Philip BM, Chu LF, Boltz MG, Kamra K, Terwey H et al. Ketamine does not increase pulmonary vascular resistance in children with pulmonary hypertension undergoing sevoflurane anesthesia and spontaneous ventilation. Anesth Analg 2007; 105:1578-1584. (Pubitemid 350190549)
68. Martin C, Perrin G, Saux P, Papazian L, Albanese J, Gouin F. Right ventricular end-systolic pressure-volume relation during propofol infusion. Acta Anaesthesiol Scand 1994; 38:223-228. (Pubitemid 24133388)
69. Boyd O, Murdoch LJ, Mackay CJ, Bennett ED, Grounds RM. The cardiovascular changes associated with equipotent anaesthesia with either propofol or isoflurane. Particular emphasis on right ventricular function. Acta Anaesthesiol Scand 1994; 38:357-362.
70. Kellow NH, Scott AD, White SA, Feneck RO. Comparison of the effects of propofol and isoflurane anaesthesia on right ventricular function and shunt fraction during thoracic surgery. Br J Anaesth 1995; 75:578-582.
71. Edanaga M, Nakayama M, Kanaya N, Tohse N, Namiki A. Propofol increases pulmonary vascular resistance during alpha-adrenoreceptor activation in normal and monocrotaline-induced pulmonary hypertensive rats. Anesth Analg 2007; 104:1121-1217. (Pubitemid 46360431)
72. Estafanous F, Barash P, Reves J, eds. Cardiac Anesthesia: Principles and Clinical Practice, 2nd ed. Lippicott Williams and Wilkins 2001; p. 598.
73. Kaye A, Baluch A, Phelps J. An analysis of remifentanil in the pulmonary vascular bed of the cat. Anesth Analg 2006; 102:118-123. (Pubitemid 43038293)
74. Ghighone M, Girling L, Prewitt R. Volume expansion versus norepinephrine in treatment of low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology 1984; 60:132-135.
75. Barash P, Nardi D, Hammond G. Catheter-induced pulmonary artery perforation. J Thorac Cardiovasc Surg 1981; 82:5-12.
76. Stobierska-Dzierzek B, Awad H, Michler R. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 2001; 38:923-931. (Pubitemid 32912691)
77. Snow D, Gray S, Ghosh S. Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery. Br J Anaesth 1994; 72:185-189. (Pubitemid 24054338)
78. Inglessis I, Shin J, Lepore J. Hemodynamic effect of inhaled nitric oxide in right ventricular myocardial infarction and cardiogenic shock. J Am Coll Cardiol 2004; 44:793-798. (Pubitemid 39099575)
79. Smedstad K, Cramb R, Morison D. Pulmonary hypertension and pregnancy: a series of eight cases. Can J Anaesth 1994; 41:502-512. (Pubitemid 24230425)
80. Kiss H, Egarter C, Asseryanis E, Putz D, Kneussl M. Primary pulmonary hypertension in pregnancy: a case report. Am J Obstet Gynecol 1995; 172:1052-1054.
81. Barst R, Rubin L, Long W. A comparison of continuous intravenous epoprostonol (prostacyclin) with conventional therapy for primary pulmonary hypertension. NEJM 1996; 334:296-301. (Pubitemid 26033085)
82. Kunimoto F, Arai M, Isa y. A comparative study of the vasodilator effects of prostaglandin E1 in patients with pulmonary hypertension after mitral valve replacement and with adult respiratory distress syndrome. Anesth Analg 1997; 85:507-512.
83. Burghuber O, Silderbauer K, Haber P. Pulmonary and antiaggregatory effects of prostacyclin after inhalation and intravenous infusion. Respiration 1984; 45:450-454. (Pubitemid 14089524)
84. Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nagdyman N, Hubler M et al. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Circulation 2003; 108 (Suppl 1):II167-173. (Pubitemid 37099949)
85. Stocker C, Penny D, Brizard C. Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. Intensive Care Medicine 2003; 29:1996-2003. (Pubitemid 37487135)
86. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W. Aerosolized prostacyclin in adult respiratory distress syndrome. Lancet 1993; 342:961-962. (Pubitemid 23305501)
87. Walmrath D, Schneider T, Schermuly R, Olschewski H, Grimminger F, Seeger W. Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996; 153:991-996. (Pubitemid 26081651)
88. Pepke-Zaba J, Higenbottam TW, Dinh-Xuan AT, Stone D, Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338:1173-1174.
89. Olshewski H, Simonneau G, Nazzareno G. Inhaled iloprost for severe pulmonary hypertension. NEJM 2002; 347:322-329.
90. Krug S, Hammerschmidt S, Pankau H, Wirtz H, Sayfarth H. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension. Respiration 2008; 76:154-159.
91. Papazian L, Roch A, Bregeon F. Inhaled nitric oxide and vasoconstrictors in acute respiratory distress syndrome. Am J Resp Crit Care Med 1999; 160:473-479. (Pubitemid 29380660)
92. Bhorade S, Christenson J, O'Connor M. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Resp Crit Care Med 1999; 159:571-579. (Pubitemid 29084883)
93. Dembinski R, Brackhahn W, Henzler D, Rott A, Bensberg R, Kuhlen R et al. Cardiopulmonary effects of iloprost in experimental acute lung injury. Eur Respir J 2005; 25:81-87. (Pubitemid 40207735)
94. Winterhalter M, Simon A, Fisher S. Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomised trial. J Cardiothorac Vasc Anesth 2008; 22:406-413.
95. Fattouch K, Sbraga F, Bianco G. Inhaled prostacyclin, nitric oxide and nitroprusside after mitral valve replacement. J Card Surg 2005; 20:171-176.
96. Theodoraki K, Rellia P, Thanopoulos A. Inhaled prostacyclin controls pulmonary hypertension after cardiopulmonary bypass. Can J Anesth 2002; 49:963-967. (Pubitemid 36097610)
97. Decoene C, Bourzoufi K, Moreau D. Use of inhaled nitric oxide for emergency cesarean section in a woman with unexpected primary pulmonary hypertension. Can J Anaesth 2001; 48:584-587. (Pubitemid 32684876)
98. Weiss B, Maggiorini M, Jenni R. Pregnant patient with primary pulmonary hypertension: inhaled pulmonary vasodilators and epidural anaesthesia for cesarean delivery. Anesthesiology 2000; 92:1191-1194. (Pubitemid 30180998)
99. Monnery L, Nanson J, Charlton G. Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. Brit J Anaesth 2001; 87:295-298. (Pubitemid 32750544)
100. Goodwin T, Gherman R, Hameed A, Elkayam U. Favorable response of Eisenmenger Syndrome to nitric oxide during pregnancy. Am J Obstet Gynecol 1999; 180:64-67. (Pubitemid 29088391)
101. Hoeper M, Olchewski H, Ghofrani H. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. J Am Coll Cardiol 2000; 35:176-182. (Pubitemid 30061277)
102. Leuchte HH, Schwaiblmair M, Baumgartner RA, Neurohr CF, Kolbe T, Behr J. Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension. Chest 2004; 125:580-586. (Pubitemid 38223639)
103. Olschewski H, Ghofrani H, Walmrath D. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Resp Crit Care Med 1999; 160:600-607. (Pubitemid 29380679)
104. Rex S, Schaelte G, Metzelder S. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomised trial. Acta Anaesthesiol Scand 2008; 52:65-72.
105. Winterhalter M, Simon A, Fischer S. Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective, randomised trial. J Cardiothorac Vasc Anesth 2008; 22:406-413.
106. Ferrer R, Masclans J, Angles R. Anticoagulative effect of nitric oxide inhalation in ARDS. Intensive Care Med 1998; 24:837-838. (Pubitemid 28431673)
107. Haraldsson A, Kieler-Jensen N, Wadenvik H, Ricksten S. Inhaled prostacyclin after cardiac surgery and cardiopulmonary bypass. Intensive Care Med 2000; 26:188-194.
108. Lowson S. Inhaled alternatives to nitric oxide. Anesthesiology 2002; 96:1504-1513. (Pubitemid 34587223)
109. Sablotzki A, Starzmann W, Scheubel R. Selective pulmonary vasodilation with inhaled aerosolised milrinone. Can J Anaesth 2005; 52:1076-1082.
110. Lamarche Y, Perrault L, Maltais S. Preliminary experience with inhaled milrinone in cardiac surgery. Eur J Cardiothorac Surg 2007; 31:1081-1087. (Pubitemid 46729654)
111. Flondor M, Merkel M, Hofstetter C, Irlbeck M, Frey L, Zwissler B. The effect of inhaled nitric oxide and inhaled iloprost on hypoxaemia in a patient with pulmonary hypertension after pulmonary thromboendarterectomy. Anaesthesia 2006; 61:1200-1203.
112. Haraldsson A, Kieler-Jensen N, Rickstein S. The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgery patients with pulmonary hypertension. Anesth Analg 2001; 93:1439-1445. (Pubitemid 33111666)
113. Ghofrani HA, Wiedemann R, Rose F, Olschewski H, Schermuly RT, Weissmann N et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 2002; 136:515-522. (Pubitemid 34252285)
114. Fok TF, Lam K, Ng PC, So HK, Cheung KL, Wong W et al. Randomised crossover trial of salbutamol aerosol delivered by metered dose inhaler, jet nebuliser, and ultrasonic nebuliser in chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1998; 79:F100-104. (Pubitemid 28419168)
115. Liu C, Chen J. Endothelin receptor antagonists for pulmonary arterial hypertension. Cochrane Database Syst Rev 2006; 3:CD004434.
116. Seyfarth S, Hammerschmidt S, Pankau H, Winkler J, Wirts H. Long-term bosentan in chronic thromboembolic pulmonary hypertension. Respiration 2007; 74:287-293. (Pubitemid 46828137)
117. Hughes RJ, Jais X, Bonderman D, Suntharalingam J, Humbert M, Lang I et al. The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study. Eur Respir J 2006; 28:138-143.
118. Schulze-Neick I, Gilbert N, Ewert R. Adult patients with congenital heart disease and pulmonary arterial hypertension: first open prospective multicenter trial of bosentan therapy. Am Heart J 2005; 150:716. (Pubitemid 41396505)
119. Ibrahim R, Granton J, Mehta S. An open-label, multicentre pilot study of bosentan in pulmonary arterial hypertension related to congenital heart disease. Can Respir J 2006; 13:415-420. (Pubitemid 46138705)
120. Gatzoulis MA, Rogers P, Li W, Harries C, Cramer D, Ward S et al. Safety and tolerability of bosentan in adults with Eisenmenger physiology. Int J Cardiol 2005; 98:147-151. (Pubitemid 40169865)
121. Austin M, McDougall N, Wendon J. Safety and efficacy of combined use of sildenafil, bosentan and iloprost before and after liver transplantation in severe portopulmonary hypertension. Liver Transpl 2008; 14:287-291.
122. Mathier M, Zhang J, Ramanathan R. Dramatic functional improvement following bariatric surgery in a patient with pulmonary arterial hypertension and morbid obesity. Chest 2008; 133:789-792.
123. Segal S, Valette S, Oster L. Risk management strategies in postmarketing period: safety with the US and European bosentan surveillance programmes. Drug Safety 2005; 28:971-978. (Pubitemid 41483704)
124. Trachte A, Lobato E, Urdenata F. Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Ann Thorac Surg 2005; 79:194-197. (Pubitemid 40037471)
125. Atz A, Wessel D. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 1999; 91:307-310. (Pubitemid 29307366)
126. Mychaskiw G, Sachdev V, Heath B. Sildenafil (Viagra) facilitates weaning of inhaled nitric oxide following placement of a bi-ventricular device. J Clin Anesth 2001; 13:218-220.
127. Behrends M, Beiderlinden M, Peters J. Combination of sildenafil and bosentan for nitric oxide withdrawal. Eur J Anaesthesiol 2005; 22:155-157. (Pubitemid 40488651)
128. Belenkie I, Horner G, Dani R, Smith E, Tyberg J. Effects of aortic constriction during experimental acute right ventricular pressure loading. Circulation 1995; 92:546-554.
129. Bergofsky EH. Humoral control of the pulmonary circulation. Annu Rev Physiol 1980; 42:221-233. (Pubitemid 10081248)
130. Ducas J, Bhattacharya S, Prewitt R. The differential hemodynamic effects of norepinephrine and methoxamine in systemic hypotension complicating pulmonary hypertension. Vasc Endovasc Surg 1995; 29:117-122.
131. Rich S, Gubin S, Hart K. The effects of phenylephrine on right ventricular performance in patients with pulmonary hypertension. Chest 1990; 98:1102-1106. (Pubitemid 20381270)
132. Kwak Y, Lee C, Park Y, Hong Y. The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension. Anaesthesia 2002; 57:9-12. (Pubitemid 34116365)
133. Hirsch L, Rooney M, Wat S, Kleinmann B, Mathru M. Norepinephrine and phenylephrine effects on right ventricular function in experimental canine pulmonary embolism. Chest 1991; 100:796-801.
134. Molloy D, Lee K, Jones D, Penner B, Prewitt R. Effects of noradrenaline and isoproteronol on cardiopulmonary function in a canine model of acute pulmonary hypertension. Chest 1985; 88:432-435. (Pubitemid 15248107)
135. Evora P, Pearson P, Schaff H. Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery.V1-receptor- mediated production of nitric oxide. Chest 1993; 103:1241-1245. (Pubitemid 23110307)
136. Jeon Y, Ryu J, Lim Y. Comparative hemodynamic effects of vasopressin and norepinephrine after milrinone-induced hypotension in off-pump coronary artery bypass surgical patients. Eur J Cardiothorac Surg 2006; 29:952-956. (Pubitemid 43728610)
137. Wallace AW, Tunin CM, Shoukas AA. Effects of vasopressin on pulmonary and systemic vascular mechanics. Am J Physiol 1989; 257:H1228-1234.
138. Leather H, Segers P, Berends N. Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension. Crit Care Med 2002; 30:2548-2551. (Pubitemid 35351877)
139. Price L, Forrest P, Sodhi V. Use of vasopressin after Caesarean section in idiopathic pulmonary hypertension. BJA 2007; 99:552-555. (Pubitemid 47412500)
140. Barrington K, Finer N, Chan W. A blind, randomised comparison of the circulatory effects of dopamine and epinephrine infusions in the newborn piglet during normoxia and hypoxia. Crit Care Med 1995; 23:740-748.
141. Le Tulzo Y, Seguin P, Gacouin A. Effects of epinephrine on right ventricular failure: a preliminary descriptive study. Intensive Care Med 1997; 23:664-670.
142. Bertolissi M, Bassi F, Da Broi U. Norepinephrine can be useful for the treatment of right ventricular failure combined with acute pulmonary hypertension and systemic hypotension: a case report. Minerva Anestesiol 2001; 67:79-84.
143. Elatrous S, Nouira S, Besbes-Ouanes L. Dobutamine in severe scorpion envenomation: effects on standard hemodynamics, right ventricular performance and tissue oxygenation. Chest 1999; 116:748-753. (Pubitemid 29428495)
144. Dell'Italia L, Starling M, Blumhart R. Comparative effects of volume loading, dobutamine and nitroprusside in severe right ventricular infarction. Circulation 1985; 72:1327-1335. (Pubitemid 16126813)
145. Ferrario M, Poli A, Previtali M, Lanzarini L, Fetiveau R, Diotallevi P et al. Hemodynamics of volume-loading compared with dobutamine in severe right ventricular infarction. Am J Cardiol 1994; 74:329-333. (Pubitemid 24253468)
146. Pagnamenta A, Fesler P, Vandinivit A, Brimioulle S, Naeije R. Pulmonary vascular effects of dobutamine in experimental pulmonary hypertension. Crit Care Med 2003; 31:1140-1146. (Pubitemid 36444426)
147. Kerbaul F, Rondolet B, Motte S. Effects of norepinephrine and dobutamine on pressure load-induced aright ventricular failure. Crit Care Med 2004; 32:1087-1089. (Pubitemid 38471527)
148. Kerbaul F, Rondolet B, Demester J. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2006; 34:2814-2819. (Pubitemid 44610948)
149. Jenkins IR, Dolman J, O'Connor JP, Ansley DM. Amrinone versus dobutamine in cardiac surgical patients with severe pulmonary hypertension after cardiopulmonary bypass: a prospective, randomized double-blinded trial. Anaesth Intensive Care 1997; 25:245-249. (Pubitemid 27296492)
150. Rathmell J, Preilipp R, Butterworth J. A multicenter, randomised, blind comparision of amrinone with milrinone after elective cardiac surgery. Anesth Analg 1998; 86:683-690. (Pubitemid 28177713)
151. Khazin V, Kaufman Y, Zabeeda D. Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children. J Cardiothorac Vasc Anesth 2004; 18:156-159. (Pubitemid 38506861)
152. Lobato E, Beaver T. Treatment with phosphodiesterase inhibitors type II and V: milrinone and sildenafil is an effective combination during thromboxane - induced acute pulmonary hypertension. Br J Anaesth 2006; 96:317-322. (Pubitemid 43280622)
153. Suzuki O. [Effect of RVAD for right heart failure involved with right ventricular infarction - especially studies of myocardial regional blood flow and epicardial mapping electrocardiography]. Nippon Kyobu Geka Gakkai Zasshi 1989; 37:1517-1525.
154. Deehring R, Kiss A, Garrett A, Hillier A. Extracorporeal membrane oxygenation as a bridge to surgical embolectomy in acute fulminant pulmonary embolism. Am J Emerg Med 2006; 24:879-890.
155. Frickey N, Kraincuk P, Zhilla I, Binder T, Plochl W. Fulminant pulmonary embolism treated by extracorporeal membrane oxygenation in a patient with traumatic brain injury. J Trauma 2008; 64:E41-43.
156. Haller I, Kofler A, Lederer W, Chemelli A, Wiedermann FJ. Acute pulmonary artery embolism during transcatheter embolization: successful resuscitation with veno-arterial extracorporeal membrane oxygenation. Anesth Analg 2008; 107:945-947.
157. Hsieh P, Wang S, Ko W, Han Y, Chu S. Successful resuscitation of acute massive pulmonary embolism with extracorporeal membrane oxygenation and open embolectomy. Ann Thorac Surg 2001; 72:266-267. (Pubitemid 32643056)
158. Szocik J, Rudich S, Cseste M. ECMO resuscitation after massive pulmonary embolism during liver transplantation. Anesthesiology 2002; 97:763-764.
159. Maggio P, Hemmila M, Haft J, Bartlett R. Extracorporeal life support for massive pulmonary embolism. J Trauma 2007; 62:570-576. (Pubitemid 46568852)
160. Gregoric I, Chandra D, Myers T. Extracorporeal membrane oxygenation as a bridge to emergency heart-lung transplantation in a patient with idiopathic pulmonary hypertension. J Heart Lung Transplant 2008; 27:466-468.
161. Giesler GM, Gomez JS, Letsou G, Vooletich M, Smalling RW. Initial report of percutaneous right ventricular assist for right ventricular shock secondary to right ventricular infarction. Catheter Cardiovasc Interv 2006; 68:263-266. (Pubitemid 44167680)
162. Atiemo AD, Conte JV, Heldman AW. Resuscitation and recovery from acute right ventricular failure using a percutaneous right ventricular assist device. Catheter Cardiovasc Interv 2006; 68:78-82. (Pubitemid 44024466)